Aqr Capital Management LLC Veracyte, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 190,292 shares of VCYT stock, worth $8.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

190,292

Previous 58,417 225.75%

Holding current value

$8.25 Million

Previous $1.27 Million 411.86%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $2.77 Million - $4.65 Million	131,875 Added 225.75%	190,292 $6.48 Million
Q2 2024 Aug 14, 2024	SELL	$18.86 - $23.55 $179,999 - $224,761	-9,544 Reduced 14.04%	58,417 $1.27 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $296,562 - $410,950	14,122 Added 26.23%	67,961 $1.51 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $287,833 - $418,613	-14,596 Reduced 21.33%	53,839 $1.48 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $363,286 - $486,768	16,269 Added 31.19%	68,435 $1.53 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $577,762 - $743,979	27,565 Added 112.05%	52,166 $1.33 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $47,066 - $63,784	2,287 Added 10.25%	24,601 $548,000
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $341,627 - $668,081	22,314 New	22,314 $529,000
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $353,343 - $684,623	-16,105 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $435,786 - $649,514	-12,075 Reduced 42.85%	16,105 $664,000
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $418,998 - $623,086	11,763 Added 71.65%	28,180 $1.31 Million
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $39,132 - $67,264	-1,188 Reduced 6.75%	16,417 $656,000
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $11,517 - $21,077	259 Added 1.49%	17,605 $946,000
Q4 2020 Feb 16, 2021	SELL	$32.49 - $61.88 $23,067 - $43,934	-710 Reduced 3.93%	17,346 $849,000
Q3 2020 Nov 16, 2020	SELL	$26.73 - $35.67 $834,858 - $1.11 Million	-31,233 Reduced 63.37%	18,056 $587,000
Q2 2020 Aug 17, 2020	SELL	$19.49 - $28.11 $2.01 Million - $2.89 Million	-102,946 Reduced 67.62%	49,289 $1.28 Million
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $903,054 - $1.69 Million	-55,986 Reduced 26.89%	152,235 $3.7 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $2.88 Million - $4.15 Million	-138,400 Reduced 39.93%	208,221 $5.81 Million
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $1.48 Million - $1.92 Million	-62,068 Reduced 15.19%	346,621 $8.32 Million
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $3.83 Million - $4.96 Million	173,504 Added 73.77%	408,689 $11.7 Million
Q1 2019 May 14, 2019	BUY	$12.0 - $25.76 $2.82 Million - $6.06 Million	235,185 New	235,185 $5.88 Million

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.1B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Veracyte, Inc. Transaction History